ArticleJournal of neuro-oncology2022

Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment.

Hye Hyeon Moon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.